Table 4.
PCI | Surgery | Reintervention | No reintervention | Significance levelb | |
---|---|---|---|---|---|
Age (years) | 66.8 ± 9 | 65.8 ± 6 | 66.6 ± 8 | 65.7 ± 10 | p = 0.321 |
Gender (m/f) | 37/15 | 9/1 | 46/16 | 37/9 | p = 0.447 |
CAD – 1VD | 1 | 0 | 1 (1.6%) | 3 (6.5%) | |
2VD | 3 | 1 | 4 (6.5%) | 4 (8.6%) | p = 0.394 |
3VD | 46 | 11 | 57 (91.9%) | 41 (81.9%) | |
Left main stem stenosis | 20 | 9 | 29 (46.7%) | 23 (50.0%) | p = 0.740 |
Acute myocardial infarction | 12 | 3 | 15 (24.1%) | 8 (17.3%) | p = 0.729 |
s/p CABG | 2 | 1 | 3 (4.8%) | 3 (6.5%) | p = 0.142 |
Hypertension | 41 | 10 | 51 (82.2%) | 34 (73.9%) | p = 0.294 |
Hyperlipidemia | 38 | 10 | 48 (77.4%) | 31 (67.3%) | p = 0.244 |
Nicotine abuse | 19 | 2 | 21 (33.8%) | 19 (34.7%) | p = 0.625 |
Diabetes mellitus | 13 | 2 | 15 (24.1%) | 15 (32.6%) | p = 0.932 |
Obesity (BMI > 30) | 7 | 2 | 9 (14.5%) | 15 (32.6%) | p = 0.025 |
Peripheral vascular disease | 10 | 2 | 12 (19.3%) | 10 (21.7%) | p = 0.092 |
Renal disease | 2 | 0 | 2 (3.2%) | 2 (4.3%) | p = 0.760 |
Pulmonary disease | 4 | 0 | 4 (6.5%) | 8 (17.3%) | p = 0.073 |
Cerebral disease | 4 | 1 | 5 (8.1%) | 4 (8.6%) | p = 0.906 |
Cardiac arrhythmias | 1 | 0 | 1 (1.6%) | 2 (4.3%) | p = 0.392 |
LV ejection fraction | 58 ± 15% | 56 ± 12% | 58 ± 14% | 59 ± 11% | p = 0.732 |
NYHA I | 11 | 5 | 16 (25.8%) | 4 (8.6%) | |
NYHA II | 11 | 1 | 12 (19.3%) | 10 (21.7%) | p = 0.148 |
NYHA III | 26 | 5 | 31 (50.0%) | 30 (65.2%) | |
NYHA IV | 2 | 1 | 3 (4.8%) | 2 (8.6%) | |
EuroScore 0–2 | 13 | 5 | 18 (36.0%)a | 12 (35.3%)a | |
EuroScore 3–5 | 20 | 4 | 24 (48.0%)a | 10 (29.4%)a | p = 0.086a |
EuroScore > 5 | 6 | 2 | 8 (16.0%)a | 12 (35.3%)a | |
Elective surgery | 25 | 4 | 29 (46.7%) | 23 (50.0%) | |
Urgent surgery | 21 | 7 | 28 (45.2%) | 17 (36.9%) | p = 0.569 |
Emergency surgery | 4 | 1 | 5 (8.1%) | 6 (13.1%) |
PCI percutaneous coronary intervention, CAD coronary artery disease, CABG coronary artery bypass operation, a = incomplete data, b Comparison of reintervention versus no reintervention